BSEIndia
      Close  
NOTICES
Notice No.   20171005-33   Notice Date   05 Oct 2017
Category   Company related   Segment   SME
Subject   Listing of Equity Shares of Vanta Bioscience Limited
Attachments   Annexure I.pdf ; Annexure II.pdf ;
Content

 Trading Members of the Exchange are hereby informed that effective from Friday, October 06, 2017 the Equity Shares of Vanta Bioscience Limited shall be listed and admitted to dealings on the SME Platform of Exchange in the list of ‘M’ Group of Securities.

 

Name of the company

Securities

Market Lot

Scrip Code

Vanta Bioscience Limited

57,28,000 equity shares of Rs. 10/- each fully paid up

 

Distinctive Nos.

1 to 5728000

 

 

3,000 Shares

 

 

540729

 

Registered Office:

 

NO.02/G/308/G,

NO.3/FF/SF/1-20-248 Umajay Complex,

Rasoolpura, Secunderabad,

Hyderabad – 500 003,

Telangana, India

Tel No: +91 40 6657 5454

Fax: +91 40 2790 8708

Email: info@vantabio.com

Website: www.vantabio.com

Abbreviated name on bolt system

 

 

 

VANTABIO

Scrip ID on BOLT System

 

 

 

VANTABIO

ISIN No.

 

 

 

 

INE695X01011

Issue Price:

 

Rs.50/- per share

(Face Value of Rs.10/- with Premium of Rs.40/-)

Date of Allotment in the public issue:

 

October 5, 2017

 

   1.     Trading Members may note that as per the guidelines issued by SEBI dated 16th February, 2000, securities of the company will only be traded in Dematerialised form. Trades effected in this scrip will be in minimum market lot (i.e. 3,000 equity shares) and the same shall be modified by the Exchange from time to time by giving prior market notice of atleast one month.

 

2.     Trading Members are requested to note that the above security will be available for trading in continuous  trading session.

 

3.     Trading Members may note that the shares bearing the distinctive numbers, the details of which are attached as Annexure I, are not transferable till the date(s) mentioned against them and would not be a good delivery in the market till then. The company has informed the Exchange that in respect of shares in physical form, the respective share certificates have been enfaced with their non-transferability. The company has informed the Exchange that in respect of shares in demat form, necessary corporate action has been executed to have the lock-in period marked in the depository’s records.

 

4.     A copy of shareholding pattern submitted by the company is enclosed as Annexure II.

 

5.     The company’s financial year ending is March 31.

 

6.     All shares are ranking pari-passu including dividend entitlement  

 

7. The Market Maker to the issue as mentioned in the prospectus is given below:

 

Inventure Growth & Securities Limited

2 nd Floor, Viraj Tower,

Nr. Andheri Flyover (North End) Western Express Highway,

Andheri (East) Mumbai – 400 069

Telephone: +91 22 3954 8500

Facsimile: +91 22 4075 1535

Email id: info@inventuregrowth.com

Contact Person: Bhavi Gandhi

Website: www.inventuregrowth.com

SEBI registration number: INB230901739

 

8.      The Registrar to the issue as mentioned in the prospectus is given below:

              

Bigshare Services Private Limited

E/2, Ansa Industrial Estate, Sakivihar Road,

Sakinaka, Andheri (East),

Mumbai – 400 072

Telephone: +91 22 40430200

Facsimile: +91 22 28475207

Email id: ipo@bigshareonline.com

Contact Person: Babu Raphael

Website: www.bigshareonline.com

SEBI registration number: INR000001385

 

 

In case members require any clarifications on the subject matter of this notice, they may please contact any of the following:

 

a) At the company:

 

Zoheb Sayani,

 

Company Secretary & Compliance Officer

Registered Office:

 

NO.02/G/308/G,

NO.3/FF/SF/1-20-248 Umajay Complex,

Rasoolpura, Secunderabad,

Hyderabad – 500 003,

Telangana, India

Tel No: +91 40 6657 5454

Fax: +91 40 2790 8708

Email: info@vantabio.com

Website: www.vantabio.com

b) At the Exchange:

     Rupal Khandelwal

     Manager

 

Tel.: (91) 022 22728262

 

 

 

 

 

 

 

 

Rupal Khandelwal

Manager

 

Thursday, October 05, 2017